X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (214) 214
female (188) 188
middle aged (139) 139
adult (122) 122
index medicus (122) 122
aged (100) 100
oncology (91) 91
male (80) 80
breast neoplasms - drug therapy (76) 76
breast cancer (62) 62
treatment outcome (52) 52
adolescent (49) 49
antineoplastic combined chemotherapy protocols - therapeutic use (47) 47
chemotherapy (45) 45
disease-free survival (43) 43
breast neoplasms - pathology (40) 40
cardiac & cardiovascular systems (38) 38
chemotherapy, adjuvant (38) 38
follow-up studies (37) 37
child (34) 34
therapy (34) 34
doxorubicin - administration & dosage (32) 32
risk factors (32) 32
survival (32) 32
cyclophosphamide - administration & dosage (31) 31
aged, 80 and over (30) 30
cancer (29) 29
article (27) 27
breast neoplasms - mortality (26) 26
prognosis (26) 26
breast neoplasms - surgery (25) 25
care and treatment (25) 25
child, preschool (25) 25
health aspects (25) 25
time factors (25) 25
women (25) 25
analysis (24) 24
young adult (24) 24
immunology (23) 23
research (23) 23
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
children (22) 22
survival analysis (21) 21
drug therapy (20) 20
retrospective studies (20) 20
clinical trials (19) 19
tamoxifen (19) 19
diagnosis (18) 18
medicine & public health (18) 18
mortality (18) 18
paclitaxel - administration & dosage (18) 18
prospective studies (18) 18
breast neoplasms - metabolism (17) 17
cyclophosphamide (17) 17
drug administration schedule (17) 17
lymphatic metastasis (17) 17
pediatrics (17) 17
rheumatology (17) 17
trastuzumab (17) 17
abridged index medicus (16) 16
breast neoplasms - genetics (16) 16
hematology (16) 16
follow-up (15) 15
infant (15) 15
medicine, general & internal (15) 15
proportional hazards models (15) 15
survival rate (15) 15
tamoxifen - administration & dosage (15) 15
tamoxifen - therapeutic use (15) 15
animals (14) 14
carcinoma (14) 14
original reports (14) 14
paclitaxel (14) 14
patients (14) 14
risk assessment (14) 14
severity of illness index (14) 14
double-blind method (13) 13
doxorubicin (13) 13
heart failure (13) 13
medical research (13) 13
mutation (13) 13
prevention (13) 13
quality of life (13) 13
risk (13) 13
transplantation (13) 13
antineoplastic agents, hormonal - therapeutic use (12) 12
cohort studies (12) 12
kaplan-meier estimate (12) 12
methotrexate (12) 12
receptors, estrogen - analysis (12) 12
trial (12) 12
antineoplastic agents - therapeutic use (11) 11
bc5 (11) 11
cells (11) 11
diseases of the circulatory system (11) 11
expression (11) 11
fluorouracil - administration & dosage (11) 11
italy (11) 11
usage (11) 11
adjuvant chemotherapy (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 25, pp. 3366 - 3373
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9707, pp. 2055 - 2063
Summary Background Tamoxifen is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of... 
Internal Medicine | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | THERAPY | CYCLOPHOSPHAMIDE | METHOTREXATE | ANTAGONISM | CARCINOMA | FLUOROURACIL CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Lymph Nodes - pathology | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Alkylating - administration & dosage | Tamoxifen - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Receptors, Progesterone - analysis | Fluorouracil - administration & dosage | Postmenopause | Adult | Female | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Adenocarcinoma - mortality | Adjuvant treatment | Breast cancer | Dosage and administration | Research | Drug therapy | Tamoxifen | Health aspects | Cancer | Heart failure | Chemotherapy | Womens health | Mortality | Clinical trials | Mammography | Radiation therapy | Cancer therapies | Tumors | Toxicity | Leukemia | Congestive heart failure | Doxorubicin | Subgroups | Rank tests | Randomization | Motivation | Registration | Mastectomy | Thromboembolism | Neutropenia | Review boards | Regression analysis | Patients | Survival | Post-menopause | Stomatitis | Cyclophosphamide | Anthracycline | Breast | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 10, pp. 923 - 932
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 436 - 446
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2007, Volume 357, Issue 15, pp. 1496 - 1506
Journal Article